GRCE logo

Grace Therapeutics, Inc.

GRCE
Healthcare|Biotechnology|US
$1.85
+0.07 (+3.93%)
DCF Value
$0.70
Tangible Book / Share
$0.72
Cash / Share
$0.80
Next Earnings Report
Nov 12, 2026
EPS est. -$0.15 · Revenue est. $1.0M
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest Aug 24, 2026 (S-3). Possible dilution.

Upcoming Data Readouts (10)

Dec 2026
Est. completion
Trigeminal Neuralgia
Observational Study on the Treatment of Trigeminal Neuralgia by Radiosurgery
NCT05677243n=150
Dec 2026
Est. completion
Cystic Fibrosis
French Validation of the AdT-Physio Scale
NCT06273566n=121
Mar 2027
Est. completion
P3NGLY1 Deficiency
Safety and Efficacy of GS-100 Gene Therapy in Patients With NGLY1 Deficiency
NCT06199531n=10
Mar 2027
Est. completion
NANutrition Security
Mississippi Community Engagement Alliance (MS CEAL): Fostering Community Solutions
NCT07071064n=400
Jun 2027
Est. completion
NAChronic Obstructive Pulmonary Disease
CHARM-COPD Program of Care
NCT06253013n=100
May 2028
Est. completion
Rapide Sequence Induction
Pain Assessment During Rapid Sequence Induction
NCT07588165n=150
Aug 2028
Est. completion
Mild Asthma
PAXT: Pulmonary Imaging of Mild Asthma Using 129Xe MRI and Tc-99-Labeled-Carbon-Imaging (Tc99CImaging)
NCT07143747n=40
Aug 2028
Est. completion
Hepatitis D Virus Infection
HDV Screening Study
NCT06889805n=300
Mar 2030
Est. completion
NAAsthma
Structure and Function MRI of Asthma
NCT02351141n=200
Jan 2032
Est. completion
NAParkinson Disease, Idiopathic
Video-oculography and Parkinson's Disease
NCT04731246n=30

Awaiting Results (4)

Trials past primary completion date but still active — data readout may be imminent.

Dec 2024
P3
Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH
NCT05995405
Dec 2024
Virtual Reality for Fibromyalgia
NCT05567861
Aug 2023
P3
Evaluation of Triple Therapy Using Magnetic Resonance Imaging in Asthma
NCT04651777
Mar 2022
NA
Evaluating the Effect of Benralizumab in Severe, Poorly-controlled Eosinophilic Asthma Using Inhaled Hyperpolarized 129-Xenon MRI
NCT03733535

Recent Press Releases

Grace Therapeutics Announces Participation in Upcoming Industry and Investor Events in November 2026
Nov 5, 2026 · GlobeNewsWire
Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference
Sep 3, 2026 · GlobeNewsWire
Grace Therapeutics Announces First Quarter 2027 Financial Results, Provides Business Update
Aug 13, 2026 · GlobeNewsWire

SEC Filings (60)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Sep 18, 20268-KMaterial eventDocumentIndex
Aug 31, 2026EFFECTDocumentIndex
Aug 24, 2026S-3Shelf registrationDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 13, 20268-KMaterial eventDocumentIndex
Aug 13, 202610-QQuarterly reportDocumentIndex
Aug 11, 2026DDocumentIndex
Aug 7, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 6, 20268-KMaterial eventDocumentIndex
Jul 28, 2026DEFA14AProxy / shareholder voteDocumentIndex
Jul 28, 2026DEF 14AProxy / shareholder voteDocumentIndex
Jul 28, 20268-KMaterial eventDocumentIndex
Jun 18, 20268-KMaterial eventDocumentIndex
Jun 18, 20268-KMaterial eventDocumentIndex
Jun 18, 202610-KAnnual reportDocumentIndex
Jun 5, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Apr 27, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Apr 27, 20268-KMaterial eventDocumentIndex
Apr 23, 20268-KMaterial eventDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 12, 20268-KMaterial eventDocumentIndex
Feb 12, 202610-QQuarterly reportDocumentIndex
Jan 28, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jan 12, 20268-KMaterial eventDocumentIndex
Nov 17, 202510-Q/AQuarterly reportDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 13, 20258-KMaterial eventDocumentIndex
Nov 13, 202510-QQuarterly reportDocumentIndex
Oct 23, 20258-KMaterial eventDocumentIndex
Sep 18, 20258-KMaterial eventDocumentIndex
Sep 12, 20258-KMaterial eventDocumentIndex
Aug 27, 20258-KMaterial eventDocumentIndex
Aug 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Aug 12, 20258-KMaterial eventDocumentIndex
Aug 12, 202510-QQuarterly reportDocumentIndex
Jul 28, 2025DEFA14AProxy / shareholder voteDocumentIndex
Jul 28, 2025DEF 14AProxy / shareholder voteDocumentIndex